European Pharmacopoeia 8th Edition Cymit
r defining the quality criteria for APIs and excipients. New monographs were added to address emerging substances and innovative pharmaceutical ingredients. This expansion reflects the dynamic nature of pharmaceutical development and the need for continuous regulat